TREGS are well-documented suppressors of T cell function capable of inhibiting anti-tumor activity through multiple mechanisms, including cell-cell contact inhibition, sequestration of IL-2 and the production of immunosuppressive cytokines such as TGF-β and IL-10 (120). This evidence concerns the gene IL2 and neoplasm.